ArticleMedicine2026
Two-sample Mendelian randomization analysis unveils a potential genetic association between rheumatic diseases and the risk of idiopathic pulmonary fibrosis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to elucidate the genetically causal link between rheumatic diseases and idiopathic pulmonary fibrosis (IPF) using Mendelian randomization (MR) analysis. Genome-wide association studies data for IPF were sourced from the FINN cohort in the IEU database, rheumatoid arthritis (RA), systemic lupus erythematosus data, and Sjögren syndrome data from the European Bioinformatics Institute, and ankylosing spondylitis data from Risteys FinnGen. We utilized single-nucleotide polymorphisms as instrumental variables using two-sample bidirectional MR analysis, which included MR-Egger, weighted median, weighted mode, and the inverse-variance weighting method. Sensitivity analysis involved various methods. Bidirectional MR analysis revealed suggestive evidence of an association between RA and IPF. After removal of outliers, the forward MR analysis showed a potential causal effect of RA on IPF using inverse-variance weighting (odds ratio [OR] = 1.24, 95% confidence interval [CI] = 1.09-1.42) and weighted median methods (OR = 1.27, 95% CI = 1.04-1.55), while MR-Egger and weighted mode analyses did not reach statistical significance. In addition, IPF was identified as a potential risk factor for RA (OR = 1.04, 95% CI = 1.01-1.07) and Sjögren syndrome (OR = 1.23, 95% CI = 1.02-1.49). However, none of the observed associations remained significant after false discovery rate correction for multiple testing. Our analysis yields suggestive evidence of a potential genetic association between rheumatic diseases and IPF, highlighting the need for further investigation into the complex interplay between these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.